AbbVie Research and Development Expenses 2010-2024 | ABBV
AbbVie research and development expenses for the twelve months ending December 31, 2024 were $12.791B, a 66.66% increase year-over-year.
- AbbVie annual research and development expenses for 2024 were $12.791B, a 66.66% increase from 2023.
- AbbVie annual research and development expenses for 2023 were $7.675B, a 17.9% increase from 2022.
- AbbVie annual research and development expenses for 2022 were $6.51B, a 5.95% decline from 2021.